(RS)9-ethyl-4,9-dihydroxy-1,2,9,10,13,15-hexahydro-12H-pyrano[4,3,2-de]pyrano[3',4':6,7]indolizino[1,2-b]quinoline-10,13-dione

ID: ALA101344

Chembl Id: CHEMBL101344

PubChem CID: 10001374

Max Phase: Preclinical

Molecular Formula: C22H18N2O6

Molecular Weight: 406.39

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Canonical SMILES:  CCC1(O)C(=O)OCc2c1cc1n(c2=O)Cc2c-1nc1ccc(O)c3c1c2CCO3

Standard InChI:  InChI=1S/C22H18N2O6/c1-2-22(28)13-7-15-18-11(8-24(15)20(26)12(13)9-30-21(22)27)10-5-6-29-19-16(25)4-3-14(23-18)17(10)19/h3-4,7,25,28H,2,5-6,8-9H2,1H3

Standard InChI Key:  NFPLDQLZDQXPDC-UHFFFAOYSA-N

Associated Targets(Human)

HOC-21 cell line (38 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
QG-56 (221 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

P388 (20296 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Mus musculus (284745 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 406.39Molecular Weight (Monoisotopic): 406.1165AlogP: 1.72#Rotatable Bonds: 1
Polar Surface Area: 110.88Molecular Species: NEUTRALHBA: 8HBD: 2
#RO5 Violations: HBA (Lipinski): 8HBD (Lipinski): 2#RO5 Violations (Lipinski):
CX Acidic pKa: 9.43CX Basic pKa: 4.42CX LogP: 0.80CX LogD: 0.79
Aromatic Rings: 3Heavy Atoms: 30QED Weighted: 0.46Np Likeness Score: 1.11

References

1. Sugimori M, Ejima A, Ohsuki S, Uoto K, Mitsui I, Matsumoto K, Kawato Y, Yasuoka M, Sato K, Tagawa H..  (1994)  Antitumor agents. 7. Synthesis and antitumor activity of novel hexacyclic camptothecin analogues.,  37  (19): [PMID:7932525] [10.1021/jm00045a007]

Source